Institutional investors purchased a net $1.3 million shares of EXAS during the quarter ended June 2017 and now own 87.36% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRED ALGER MANAGEMENT, INC. Bought 2.4 Million shares of Exact Sciences Corp
WELLINGTON MANAGEMENT CO. LLP Bought 2.2 Million shares of Exact Sciences Corp
UBS SECURITIES LLC Bought 1.4 Million shares of Exact Sciences Corp